Zhende Medical Hits Day Low of CNY 80.00 Amid Price Pressure

Zhende Medical Co., a large-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 3.5% as of June 5, 2026. The stock reached an intraday low of CNY 80.00, reflecting a challenging trading environment. In terms of performance metrics, Zhende Medical has faced a downward trend over various time frames. The company's one-week performance shows a decrease of 3.99%, while the one-month performance is down by 13.15%. Despite these recent declines, the stock has demonstrated significant growth over the past year, with a remarkable increase of 284.46%, outpacing the China Shanghai Composite's 19.02% gain. Financially, Zhende Medical's net sales have contracted at an annual rate of 13.03% over the last five years, and its operating profit has decreased by 36.96%. The company reported a net profit of CNY 152.7 million, reflecting a decline of 35.01%. Additionally, the debt-equity ratio stands at a high 5.96%, indicating a leveraged position. Despite these challenges, the stock maintains a high dividend yield of 1.5%.